Qube Research & Technologies LTD Tyra Biosciences, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$11.61 - $20.0 $50,840 - $87,580
4,379 Added 165.06%
7,032 $115,000
Q4 2023

Feb 13, 2024
BUY
$11.01 - $14.95 $29,209 - $39,662
2,653 New
2,653 $36,000
Q4 2021

Feb 01, 2022
SELL
$12.23 - $31.35 $140,106 - $359,145
-11,456 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$16.91 - $26.0 $193,720 - $297,856
11,456 New
11,456 $202,000

Others Institutions Holding TYRA

# of Institutions
98
Shares Held
43.5M
Call Options Held
353K
Put Options Held
1.1K
View Full List

About Tyra Biosciences, Inc.

TYRA Quotes by TradingView
  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $646M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email